Redalpine led the pre-seed round to help the startup bring its wearable hormone sensors to market and expand its team.
"We did it for blood pressure and will do it again for hormones. Continuous hormone measurement is one of the holy grails of diagnostics, and as fundamental science transitions to engineering, we couldn’t be more excited to back Level Zero Health in their mission to transform hormone tracking with their novel biosensor – paving the way for a new era of personalized health management."
The funding round was led by Highland Europe with participation from multiple existing investors.
"From the moment we started building at our kitchen table, 9fin has pioneered the use of AI in debt capital markets, setting a new industry standard. By investing in the best product and engineering talent, we’ve dramatically increased product velocity, delivering capabilities to give our customers the best workflows, tools and insights, and helping them navigate easily through complex financial markets."
Spark Capital led the Series A round, which will fund US expansion and team growth.
"Steven, Hussam and the 9fin team are updating an industry that desperately needs it. They’ve made so much progress out of their London office, we’re excited to see them take on the US and continue growing with new customers."
Redalpine led the Series A round with participation from Fly Ventures and various angel investors to support growth across the Atlantic.
"Debt capital markets is the world’s largest asset class, but it operates using the worst quality data, information, and technology. Many companies in this space aren’t large listed businesses, they’re privately owned, that means important information about them isn’t readily or easily available."
